COCRYSTAL PHARMA, INC. Marketable Securities (Current)
COCRYSTAL PHARMA, INC. (COCP) had Marketable Securities (Current) of $993.00 thousand as of 2015-03-31, per its 10-Q filed 2015-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:MarketableSecuritiesCurrent · last filed 2015-11-16
- 2015-03-31: Marketable Securities, Current $993.00K.
- 2014-12-31: Marketable Securities, Current $1.98M.
- 2014-09-30: Marketable Securities, Current $2.50M.
- 2014-06-30: Marketable Securities, Current $5.72M.
| Period end | Marketable Securities, Current |
|---|---|
| 2015-03-31 | $993.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $1.98M 10-Q · filed 2015-11-16 |
| 2014-09-30 | $2.50M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $5.72M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $7.29M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |